174 related articles for article (PubMed ID: 14986247)
21. Antimicrobial susceptibility of Clostridium difficile by E test.
Cheng SH; Chu FY; Lo SH; Lu JJ
J Microbiol Immunol Infect; 1999 Jun; 32(2):116-20. PubMed ID: 11561576
[TBL] [Abstract][Full Text] [Related]
22. Hospital-wide restriction of clindamycin: effect on the incidence of Clostridium difficile-associated diarrhea and cost.
Climo MW; Israel DS; Wong ES; Williams D; Coudron P; Markowitz SM
Ann Intern Med; 1998 Jun; 128(12 Pt 1):989-95. PubMed ID: 9625685
[TBL] [Abstract][Full Text] [Related]
23. Clindamycin resistant strains of Clostridium difficile isolated from cases of C. difficile associated diarrhea (CDAD) in a hospital in Sweden.
Norén T; Tang-Feldman YJ; Cohen SH; Silva J; Olcén P
Diagn Microbiol Infect Dis; 2002 Feb; 42(2):149-51. PubMed ID: 11858913
[TBL] [Abstract][Full Text] [Related]
24. Antimicrobial resistance in Clostridioides (Clostridium) difficile derived from humans: a systematic review and meta-analysis.
Sholeh M; Krutova M; Forouzesh M; Mironov S; Sadeghifard N; Molaeipour L; Maleki A; Kouhsari E
Antimicrob Resist Infect Control; 2020 Sep; 9(1):158. PubMed ID: 32977835
[TBL] [Abstract][Full Text] [Related]
25. First cluster of clindamycin-resistant Clostridium difficile PCR ribotype 027 in Switzerland.
Fenner L; Widmer AF; Stranden A; Conzelmann M; Goorhuis A; Harmanus C; Kuijper EJ; Frei R
Clin Microbiol Infect; 2008 May; 14(5):514-5. PubMed ID: 18399816
[No Abstract] [Full Text] [Related]
26. Effects of fluoroquinolone restriction (from 2007 to 2012) on Clostridium difficile infections: interrupted time-series analysis.
Sarma JB; Marshall B; Cleeve V; Tate D; Oswald T; Woolfrey S
J Hosp Infect; 2015 Sep; 91(1):74-80. PubMed ID: 26169793
[TBL] [Abstract][Full Text] [Related]
27. What have we learned about antimicrobial use and the risks for Clostridium difficile-associated diarrhoea?
Blondeau JM
J Antimicrob Chemother; 2009 Feb; 63(2):238-42. PubMed ID: 19028718
[TBL] [Abstract][Full Text] [Related]
28. Epidemic Clostridium difficile.
Polk RE; Oinonen M; Pakyz A
N Engl J Med; 2006 Mar; 354(11):1199-203; author reply 1199-203. PubMed ID: 16544388
[No Abstract] [Full Text] [Related]
29. The new Clostridium difficile--what does it mean?
Bartlett JG; Perl TM
N Engl J Med; 2005 Dec; 353(23):2503-5. PubMed ID: 16322604
[No Abstract] [Full Text] [Related]
30. Clostridium difficile and fluoroquinolones: is there a link?
Weiss K
Int J Antimicrob Agents; 2009 Mar; 33 Suppl 1():S29-32. PubMed ID: 19303566
[TBL] [Abstract][Full Text] [Related]
31. Antimicrobial-associated risk factors for Clostridium difficile infection.
Owens RC; Donskey CJ; Gaynes RP; Loo VG; Muto CA
Clin Infect Dis; 2008 Jan; 46 Suppl 1():S19-31. PubMed ID: 18177218
[TBL] [Abstract][Full Text] [Related]
32. Fluoroquinolone use and risk factors for Clostridium difficile-associated disease within a Veterans Administration health care system.
McFarland LV; Clarridge JE; Beneda HW; Raugi GJ
Clin Infect Dis; 2007 Nov; 45(9):1141-51. PubMed ID: 17918075
[TBL] [Abstract][Full Text] [Related]
33. Risk factors and mortality associated with Clostridium difficile-associated diarrhoea at a VA hospital.
Changela U; Cannon JP; Aneziokoro C; Shah PS; Thottapurathu L; Lentino J
Int J Antimicrob Agents; 2004 Dec; 24(6):562-6. PubMed ID: 15555878
[TBL] [Abstract][Full Text] [Related]
34. Prevalence of antimicrobial resistance and association with toxin genes in Clostridium difficile in commercial swine.
Thakur S; Putnam M; Fry PR; Abley M; Gebreyes WA
Am J Vet Res; 2010 Oct; 71(10):1189-94. PubMed ID: 20919905
[TBL] [Abstract][Full Text] [Related]
35. Fluoroquinolone use is the predominant risk factor for the development of a new strain of clostridium difficile-associated disease.
Patel NS
BJU Int; 2007 Jun; 99(6):1333-4. PubMed ID: 17233799
[No Abstract] [Full Text] [Related]
36. Clindamycin formulary restriction lowers costs, antimicrobial resistance.
Am J Health Syst Pharm; 1998 Aug; 55(15):1552. PubMed ID: 9706176
[No Abstract] [Full Text] [Related]
37. Inflammatory Bowel Disease and Clostridium difficile-associated diarrhea: a growing problem.
Tremaine WJ
Clin Gastroenterol Hepatol; 2007 Mar; 5(3):310-1. PubMed ID: 17368229
[No Abstract] [Full Text] [Related]
38. Clostridium difficile: changing epidemiology and new treatment options.
Kuijper EJ; van Dissel JT; Wilcox MH
Curr Opin Infect Dis; 2007 Aug; 20(4):376-83. PubMed ID: 17609596
[TBL] [Abstract][Full Text] [Related]
39. Collateral damage. The rise of resistant C. difficile.
Taubes G
Science; 2008 Jul; 321(5887):360. PubMed ID: 18635789
[No Abstract] [Full Text] [Related]
40. Strains and toxins of Clostridium.
Vinh DC
CMAJ; 2005 Feb; 172(3):312-3; author reply 313. PubMed ID: 15684103
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
